CD ComputaBio Issues Global Simulations of Enzymatic Catalysis for Science Growth

After several years of experience accumulation, CD ComputaBio has grown into a professional provider of computational biology service in the world. Not long ago, CD ComputaBio announced the launch of global simulations of enzymatic catalysis for laboratories and research teams all over the world. The release of this service by CD ComputaBio will promote a big step forward in basic research related to drug discovery and drug design.

 For scientists who want to quickly get the experimental results to promote the research process, it is obviously essential to make full use of enzymatic catalysis to carry out experiments. Relying on the feature of low enzymes consumption but high catalytic efficiency, this technology can increase the speed of biochemical reactions, which originally would take several years to complete, by well over a million-fold in an instant, greatly saving experimenters’ time. And by virtue of this property, enzymatic catalysis ranks among researchers’ favorite technologies as well.

 Enzymatic catalysis has become one of the most commonly applied technologies for drug design. The use of enzymes in organic synthesis for pharmaceutical industry is the most prominent example. The synthesis of many antibiotics as well as the production of chiral drugs and chiral precursor substances have utilized this technology. In addition, enzymatic catalysis is used on a large scale to make specialty and even bulk chemicals. And with the rise of chiral technology, enzymatic catalysis will continue to play an important role in the future.

CD ComputaBio has experienced experimenters and research teams, and is proficient in the advanced multi-scale models and simulation methods. Adopting these models and methods, the company can carry out the full-scale simulation research on the enormous and complicated enzymatic catalytic process, assisting researchers to analyze the molecular mechanism of this process at the atomic and electronic level, so as to help scientists overcome the limitations of the original experimental methods and make breakthroughs.

In addition, CD ComputaBio extensively combines various computational technologies, such as QM/MM simulation and molecular dynamic simulation, to perform free energy calculations and key residue analysis, which will greatly enrich scientists’ understanding of enzyme catalytic activity. And other services provided by the company, such as enzyme molecular dynamics simulation, will further support researches in enzyme engineering pharmaceuticals as well. “To become a senior provider of global simulations of enzymatic catalysis is our ultimate goal in this direction,” a spokesman from CD ComputaBio said.

About CD ComputaBio

CD ComputaBio is a professional supplier of computational biology service. Over the years, the company has continuously expanded its service line to meet the research needs of scientists and experimenters in a comprehensive way. At present, the services provided by CD ComputaBio mainly include Virtual Screening Service, Univariate Analysis and so on. For more information, please visit the website: https://www.computabio.com/